Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) — Financial Flexibility Index
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) has a Financial Flexibility Index of -0.04x as of September 2025. Free cash flow of CN¥-12.90 Million (operating CF CN¥-19.96 Million minus capex CN¥7.06 Million) represents 0% of total liabilities (CN¥335.43 Million). Also explore Hangzhou TianMuShan Pharmaceutical Enter annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Financial Flexibility Index (1998–2024)
Historical Financial Flexibility Index trend for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd across 27 annual periods. Check strategic asset allocation of Hangzhou TianMuShan Pharmaceutical Enter to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (1998–2024)
Year-by-year free cash flow to debt coverage for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. For the full company profile including market capitalisation, see Hangzhou TianMuShan Pharmaceutical Enter market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.05x | CN¥-16.12 Million | CN¥-36.67 Million | CN¥356.44 Million | ▼ -14.5% |
| 2023 | -0.04x | CN¥-11.47 Million | CN¥-20.43 Million | CN¥290.34 Million | ▲ +26.4% |
| 2022 | -0.05x | CN¥-15.85 Million | CN¥-19.37 Million | CN¥295.36 Million | ▲ +16.4% |
| 2021 | -0.06x | CN¥-21.71 Million | CN¥-26.42 Million | CN¥338.09 Million | ▼ -751.8% |
| 2020 | 0.01x | CN¥3.44 Million | CN¥-8.40 Million | CN¥349.18 Million | ▼ -98.5% |
| 2019 | 0.65x | CN¥255.78 Million | CN¥161.13 Million | CN¥393.60 Million | ▲ +139.7% |
| 2018 | 0.27x | CN¥108.17 Million | CN¥70.71 Million | CN¥398.99 Million | ▲ +10.7% |
| 2017 | 0.24x | CN¥86.77 Million | CN¥24.52 Million | CN¥354.18 Million | ▲ +119.2% |
| 2016 | 0.11x | CN¥26.82 Million | CN¥1.61 Million | CN¥240.01 Million | ▲ +113.0% |
| 2015 | 0.05x | CN¥11.42 Million | CN¥-1.47 Million | CN¥217.63 Million | ▼ -66.2% |
| 2014 | 0.16x | CN¥31.11 Million | CN¥653.79K | CN¥200.40 Million | ▲ +48.9% |
| 2013 | 0.10x | CN¥23.98 Million | CN¥12.37 Million | CN¥230.01 Million | ▲ +210.1% |
| 2012 | -0.09x | CN¥-19.24 Million | CN¥-19.82 Million | CN¥203.17 Million | ▼ -6231.4% |
| 2011 | 0.00x | CN¥-261.74K | CN¥-6.49 Million | CN¥175.00 Million | ▼ -126.7% |
| 2010 | 0.01x | CN¥928.13K | CN¥-12.60 Million | CN¥165.66 Million | ▼ -97.8% |
| 2009 | 0.26x | CN¥36.33 Million | CN¥7.58 Million | CN¥140.53 Million | ▼ -12.1% |
| 2008 | 0.29x | CN¥37.88 Million | CN¥21.19 Million | CN¥128.78 Million | ▼ -70.6% |
| 2007 | 1.00x | CN¥131.36 Million | CN¥47.53 Million | CN¥131.16 Million | ▲ +67.7% |
| 2006 | 0.60x | CN¥69.29 Million | CN¥55.39 Million | CN¥116.04 Million | ▲ +297.6% |
| 2005 | 0.15x | CN¥20.02 Million | CN¥8.48 Million | CN¥133.32 Million | ▲ +62.0% |
| 2004 | 0.09x | CN¥9.78 Million | CN¥1.35 Million | CN¥105.49 Million | ▲ +131.1% |
| 2003 | -0.30x | CN¥-30.94 Million | CN¥-41.13 Million | CN¥103.88 Million | ▼ -190.3% |
| 2002 | 0.33x | CN¥39.70 Million | CN¥21.80 Million | CN¥120.32 Million | ▲ +166.0% |
| 2001 | 0.12x | CN¥19.49 Million | CN¥10.52 Million | CN¥157.11 Million | ▲ +262.4% |
| 2000 | 0.03x | CN¥5.29 Million | CN¥-9.67 Million | CN¥154.60 Million | ▼ -95.1% |
| 1999 | 0.70x | CN¥66.62 Million | CN¥49.09 Million | CN¥95.68 Million | ▲ +183.3% |
| 1998 | 0.25x | CN¥21.46 Million | CN¥2.36 Million | CN¥87.30 Million | — |